Royal Bank of Canada’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
14,438
+13,979
| +3,046% | +$111K | ﹤0.01% | 5201 |
|
|
2025
Q1 | $4K | Buy |
+459
| New | +$4K | ﹤0.01% | 6038 |
|
|
2024
Q4 | – | Sell |
-411
| Closed | -$7K | – | 6593 |
|
|
2024
Q3 | $7K | Buy |
411
+25
| +6% | +$426 | ﹤0.01% | 5963 |
|
|
2024
Q2 | $10K | Buy |
386
+190
| +97% | +$4.92K | ﹤0.01% | 5955 |
|
|
2024
Q1 | $14K | Sell |
196
-961
| -83% | -$68.6K | ﹤0.01% | 5625 |
|
|
2023
Q4 | $231K | Buy |
1,157
+622
| +116% | +$124K | ﹤0.01% | 4460 |
|
|
2023
Q3 | $71K | Buy |
535
+139
| +35% | +$18.4K | ﹤0.01% | 5101 |
|
|
2023
Q2 | $59K | Buy |
396
+185
| +88% | +$27.6K | ﹤0.01% | 5247 |
|
|
2023
Q1 | $31K | Sell |
211
-163
| -44% | -$23.9K | ﹤0.01% | 5474 |
|
|
2022
Q4 | $59K | Buy |
374
+334
| +835% | +$52.7K | ﹤0.01% | 5316 |
|
|
2022
Q3 | $8K | Buy |
40
+22
| +122% | +$4.4K | ﹤0.01% | 6054 |
|
|
2022
Q2 | $3K | Sell |
18
-146
| -89% | -$24.3K | ﹤0.01% | 6381 |
|
|
2022
Q1 | $29K | Sell |
164
-396
| -71% | -$70K | ﹤0.01% | 5920 |
|
|
2021
Q4 | $164K | Buy |
560
+337
| +151% | +$98.7K | ﹤0.01% | 5008 |
|
|
2021
Q3 | $55K | Buy |
223
+69
| +45% | +$17K | ﹤0.01% | 5586 |
|
|
2021
Q2 | $39K | Buy |
154
+73
| +90% | +$18.5K | ﹤0.01% | 5708 |
|
|
2021
Q1 | $14K | Buy |
81
+35
| +76% | +$6.05K | ﹤0.01% | 6142 |
|
|
2020
Q4 | $8K | Buy |
46
+44
| +2,200% | +$7.65K | ﹤0.01% | 5931 |
|
|
2020
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 6314 |
|
|
2020
Q2 | $0 | Sell |
1
-63
| -98% | – | ﹤0.01% | 6279 |
|
|
2020
Q1 | $11K | Buy |
64
+51
| +392% | +$8.77K | ﹤0.01% | 5301 |
|
|
2019
Q4 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 5888 |
|